Next generation therapy trackers (TheraTrack) platform includes dynamic, up-to-date trackers of assets in development across cell therapies, viral gene therapies, nucleic acid based therapies, and antibody-drug conjugates.
DeciBio’s drug development trackers track and segment novel therapeutic programs in development (e.g., cell therapies, viral gene therapies, oligos) across preclinical and clinical development. These trackers give you a comprehensive lens into the nucleic acid therapy drug development space. We aggregate, track, and synthesize data from multiple sources to curate robust, actionable insights on programs in development across indications and sponsors. Minimize cumbersome searching by accessing the research we have done for you. The database may be used to perform custom analyses on specific therapeutic classesor indications.
Request a demo to explore how our turnkey trackers may help accelerate your project’s success. Find a one-stop-shop to probe the development landscape across cell, gene, and oligo therapeutic pipelines with information on ~1,000 therapies in development.